The Obeticholic Acid Market is undergoing a transformative phase as the demand for targeted liver disease therapies rises globally. According to DataIntelo’s latest research report, the market is expected to experience significant growth over the coming years, driven by increasing cases of chronic liver conditions and advancements in pharmaceutical development. Valued at USD 1.3 billion...

The Obeticholic Acid Market is on a significant upward trajectory, propelled by the increasing prevalence of chronic liver diseases, notably Primary Biliary Cholangitis (PBC) and Non-Alcoholic Steatohepatitis (NASH). Obeticholic acid, a potent farnesoid X receptor (FXR) agonist, is gaining momentum as a targeted therapeutic option, especially where conventional treatments fail. Valued at USD...